NCT00478738View on ClinicalTrials.gov

A 2 Part Study Examining Doses Of GSK961081 In Healthy Volunteers And Then In COPD Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

GSK961081

Trial Locations (5)

6530

GSK Investigational Site, George

7700

GSK Investigational Site, Mowbray

9301

GSK Investigational Site, Bloemfontein

14050

GSK Investigational Site, Berlin

55131

GSK Investigational Site, Mainz

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00478738 - A 2 Part Study Examining Doses Of GSK961081 In Healthy Volunteers And Then In COPD Patients | Biotech Hunter | Biotech Hunter